SCHEMBL4257736

SCHEMBL4257736

COc1cc(F)cc2c(NC(=O)C3CC3)c(C(N)=O)oc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
KDM4E B2RXH2 5/20 0.45
TSHR P16473 4/20 0.45
ALDH1A1 P00352 3/20 0.45
HTT P42858 2/20 0.45
GSK3B P49841 2/20 0.41
MAPT P10636 4/20 0.40
HSD17B10 Q99714 4/20 0.40
DHODH Q02127 2/20 0.40
PARP1 P09874 2/20 0.40
RXFP1 Q9HBX9 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HPGD P15428 3/20 0.40
ALOX15 P16050 1/20 0.40
POLB P06746 2/20 0.40
ATM Q13315 1/20 0.39
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4254511 0.85 TSHR (0.49) MEN1KMT2AKDM4ETSHRALDH1A1
SCHEMBL4254136 0.83 KDM4E (0.47) MEN1KMT2AKDM4ETSHRALDH1A1
SCHEMBL4249407 0.81 TSHR (0.53) MEN1KMT2AKDM4ETSHRALDH1A1
SCHEMBL13699881 0.80 MAPT (0.57) MEN1KMT2AKDM4ETSHRALDH1A1
SCHEMBL4251235 0.78 MAPT (0.51) MEN1KMT2AKDM4ETSHRALDH1A1
SCHEMBL13699913 0.78 TP53 (0.49) MEN1KMT2AKDM4ETSHRALDH1A1
SCHEMBL13699883 0.78 MAPT (0.48) MEN1KMT2AKDM4ETSHRALDH1A1
SCHEMBL13700090 0.76 GRM4 (0.49) MEN1KMT2AKDM4ETSHRMAPT
SCHEMBL13699911 0.76 TP53 (0.47) MEN1KMT2ATSHRALDH1A1MAPT
SCHEMBL4254383 0.76 KDM4E (0.38) MEN1KMT2AKDM4EALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US claimed
EP-1710233-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE Kissei Pharmaceutical Co., Ltd. (JP) 2006-10-11 EP claimed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
EP-1710233-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE Kissei Pharmaceutical Co., Ltd. (JP) 2006-10-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F MEN1 4409/4885KMT2A 2861/4885KDM4E 4227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.